Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea V Lopez

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Immunology Research|March 28, 2020
Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T CellsDinali Wijewarnasuriya, Christina Bebernitz, Andrea V Lopez, et al.
Leukemia|May 25, 2020
Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor responseXinghuo Li, Anthony F Daniyan, Andrea V Lopez, et al.
Nature Communications|December 3, 2020
CD103<sup>+</sup> cDC1 and endogenous CD8<sup>+</sup> T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor functionNicholas F Kuhn, Andrea V Lopez, Xinghuo Li, et al.
Cancer Immunology Research|March 27, 2020
Optimization of T-cell Receptor-Modified T Cells for Cancer TherapyDylan J Drakes, Sarwish Rafiq, Terence J Purdon, et al.
The Journal of Clinical Investigation|March 23, 2023
IL-18-secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer modelsJanneke E Jaspers, Jonathan F Khan, William D Godfrey, et al.
Cancer Cell|March 20, 2019
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor ResponseNicholas F Kuhn, Terence J Purdon, Dayenne G van Leeuwen, et al.
Blood Cancer Discovery|October 22, 2020
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple MyelomaCarlos Fernández de Larrea, Mette Staehr, Andrea V Lopez, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Autoantibodies Drive Fcγ Receptor-Dependent Colon Inflammation During Immune Checkpoint BlockadeIryna Voloshyna, Yury Patskovsky, Sabina Sandigursky, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Immunology Research|March 28, 2020
Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T CellsDinali Wijewarnasuriya, Christina Bebernitz, Andrea V Lopez, et al.
Leukemia|May 25, 2020
Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor responseXinghuo Li, Anthony F Daniyan, Andrea V Lopez, et al.
Nature Communications|December 3, 2020
CD103<sup>+</sup> cDC1 and endogenous CD8<sup>+</sup> T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor functionNicholas F Kuhn, Andrea V Lopez, Xinghuo Li, et al.
Cancer Immunology Research|March 27, 2020
Optimization of T-cell Receptor-Modified T Cells for Cancer TherapyDylan J Drakes, Sarwish Rafiq, Terence J Purdon, et al.
The Journal of Clinical Investigation|March 23, 2023
IL-18-secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer modelsJanneke E Jaspers, Jonathan F Khan, William D Godfrey, et al.
Cancer Cell|March 20, 2019
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor ResponseNicholas F Kuhn, Terence J Purdon, Dayenne G van Leeuwen, et al.
Blood Cancer Discovery|October 22, 2020
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple MyelomaCarlos Fernández de Larrea, Mette Staehr, Andrea V Lopez, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Autoantibodies Drive Fcγ Receptor-Dependent Colon Inflammation During Immune Checkpoint BlockadeIryna Voloshyna, Yury Patskovsky, Sabina Sandigursky, et al.
Pageof 1